<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02189850</url>
  </required_header>
  <id_info>
    <org_study_id>BLI800-501</org_study_id>
    <nct_id>NCT02189850</nct_id>
  </id_info>
  <brief_title>Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Braintree Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Braintree Laboratories</source>
  <brief_summary>
    <textblock>
      The purpose o this study is to evaluate the safety, tolerance and efficacy of BLI800 as a
      bowel preparation prior to colonoscopy in pediatric patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% of subjects with treatment emergent adverse events</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>% of subjects with successful preparation rated by colonoscopist on a 4 point scale (1=poor to 4 = excellent)</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serum chemistry parameters</measure>
    <time_frame>9 days</time_frame>
    <description>Change in serum chemistry parameters from screening (ALT, AST, bicarbonate, total bilirubin, blood urea nitrogen, calcium, chloride, creatine kinase, creatinine, eGFR, GGT, HCG, magnesium, phosphorus, potassium, sodium, anion gap, total protein, uric acid and osmolality).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>BLI800 - Dose 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BLI800 oral solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BLI800 - Dose 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BLI800 oral solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BLI800 - Dose 1</intervention_name>
    <description>BLI800 oral solution</description>
    <arm_group_label>BLI800 - Dose 1</arm_group_label>
    <other_name>BLI800</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BLI800 - Dose 2</intervention_name>
    <description>BLI800 oral solution</description>
    <arm_group_label>BLI800 - Dose 2</arm_group_label>
    <other_name>BLI800</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Male or female between the ages of 12 to 17

          -  Weight more than 40kg

          -  Undergoing colonoscopy for routinely accepted indications

          -  If female, and of child-bearing potential, subject must use an acceptable form of
             birth control or remain abstinent for the duration of the study.

          -  Negative pregnancy test at screening, if applicable

          -  In the Investigator's judgment, caregiver is mentally competent to provide informed
             consent for their child to participate in the study.

        Exclusion Criteria:

          -  Subjects with known or suspected ileus, impaction, severe ulcerative colitis, acute
             peritonitis, gastrointestinal obstruction, gastric retention (gastroparesis), bowel
             perforation, toxic colitis or megacolon.

          -  Subjects who had previous significant gastrointestinal surgeries.

          -  Subjects with increased risk of bowel perforation, including connective tissue
             disorders, toxic dilation of the bowel or recent bowel surgery.

          -  Subjects with uncontrolled pre-existing electrolyte abnormalities, or those with
             clinically significant electrolyte abnormalities based on Visit 1 laboratory results

          -  Subjects with bleeding disorders and/or impaired platelet function, or neutropenia.

          -  Subjects with a prior history of renal, liver or cardiac insufficiency

          -  Subjects required to take any other oral medication within 3 hours of dosing until
             completion of both doses.

          -  Subjects with impaired consciousness that predisposes them to pulmonary aspiration.

          -  Subjects with tendency for nausea and/or vomiting, or that have known swallowing
             disorders.

          -  Subjects for whom intake of substances is likely to affect gastrointestinal motility
             or urinary flow rate.

          -  Subjects undergoing colonoscopy for foreign body removal and/or decompression.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Arkansas Children's Hospital Research Institute</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Center for Digestive Health Care</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delta Research Partners</name>
      <address>
        <city>Bastrop</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastrointestinal Associates</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Buffalo Pediatric Associates</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2014</study_first_submitted>
  <study_first_submitted_qc>July 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2014</study_first_posted>
  <disposition_first_submitted>July 18, 2016</disposition_first_submitted>
  <disposition_first_submitted_qc>July 18, 2016</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">July 19, 2016</disposition_first_posted>
  <last_update_submitted>July 18, 2016</last_update_submitted>
  <last_update_submitted_qc>July 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colonoscopy</keyword>
  <keyword>pediatric</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

